|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | (2013.01) |
| A61K 31/10 | (2006.01) | ||
| A61K 31/445 | (2006.01) | ||
| A61K 31/196 | (2013.01) | ||
| A61K 31/407 | (2013.01) | ||
| A61K 31/473 | (2006.01) | ||
| A61K 31/4545 | (2013.01) | ||
| A61K 31/60 | (2006.01) | ||
| A61K 31/495 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/60 | (2013.01) | ||
| A61K 31/603 | (2013.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61K 31/445 | (2013.01) | ||
| A61K 31/196 | (2006.01) | ||
| A61K 31/192 | (2013.01) | ||
| A61K 31/407 | (2006.01) | ||
| A61K 9/0056 | (2013.01) | ||
| A61P 1/02 | (2006.01) | ||
| A61P 1/02 | (2018.01) | ||
| A61P 3/02 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 3/02 | (2018.01) | ||
| A61P 39/02 | (2006.01) | ||
| A61P 39/02 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61K 31/495 | (2006.01) | ||
| A61K 31/603 | (2006.01) |
| (11) | Patento numeris | 3273952 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16769429.8 |
| Europos patento paraiškos padavimo data | 2016-03-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/023200 |
| Data | 2016-03-18 |
| (87) | Numeris | WO 2016/154028 |
| Data | 2016-09-29 |
| (30) | Numeris | Data | Šalis |
| 201562138665 P | 2015-03-26 | US |
| (72) |
IVERSEN, Jacqueline M. , US
IVERSEN, James M. , US
|
| (73) |
Sen-Jam Pharmaceutical LLC ,
223 Wall Street 130, Huntington, New York 11743,
US
|
| (54) | COMBINATION OF NAPROXEN AND FEXOFENADINE TO INHIBIT SYMPTOMS ASSOCIATED WITH VEISALGIA |
| COMBINATION OF NAPROXEN AND FEXOFENADINE TO INHIBIT SYMPTOMS ASSOCIATED WITH VEISALGIA |